MetLife Investment Management’s Artivion AORT Stock Holding History

MetLife Investment Management’s Portfolio AORT Stock Details AORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$601K	Buy	26,749 +3,235	+14%	+$90.5K	﹤0.01%	1808
2026 Q1	$861K	Buy	23,514 +458	+2%	+$18.1K	﹤0.01%	1476
2025 Q4	$1.05M	Buy	23,056 +606	+3%	+$27K	0.01%	1397
2025 Q3	$951K	Sell	22,450 -1,219	-5%	-$45.9K	﹤0.01%	1479
2025 Q2	$736K	Sell	23,669 -202	-0.8%	-$5.47K	﹤0.01%	1473
2025 Q1	$587K	Sell	23,871 -232	-1%	-$6.44K	﹤0.01%	1643
2024 Q4	$689K	Buy	24,103 +1,671	+7%	+$46.4K	﹤0.01%	1618
2024 Q3	$597K	Hold	22,432	–	–	﹤0.01%	1677
2024 Q2	$575K	Buy	22,432 +2,157	+11%	+$48.3K	﹤0.01%	1648
2024 Q1	$429K	Hold	20,275	–	–	﹤0.01%	1760
2023 Q4	$363K	Hold	20,275	–	–	﹤0.01%	1878
2023 Q3	$307K	Hold	20,275	–	–	﹤0.01%	1939
2023 Q2	$349K	Hold	20,275	–	–	﹤0.01%	1927
2023 Q1	$266K	Hold	20,275	–	–	﹤0.01%	2053
2022 Q4	$246K	Hold	20,275	–	–	﹤0.01%	2120
2022 Q3	$281K	Hold	20,275	–	–	﹤0.01%	2072
2022 Q2	$383K	Hold	20,275	–	–	﹤0.01%	1851
2022 Q1	$433K	Buy	20,275 +7,545	+59%	+$146K	﹤0.01%	1857
2021 Q4	$259K	Hold	12,730	–	–	﹤0.01%	1892
2021 Q3	$284K	Hold	12,730	–	–	﹤0.01%	1855
2021 Q2	$362K	Hold	12,730	–	–	﹤0.01%	1771
2021 Q1	$287K	Sell	12,730 -4,490	-26%	-$110K	﹤0.01%	1838
2020 Q4	$407K	Hold	17,220	–	–	﹤0.01%	1588
2020 Q3	$318K	Hold	17,220	–	–	﹤0.01%	1598
2020 Q2	$330K	Hold	17,220	–	–	﹤0.01%	1613
2020 Q1	$291K	Hold	17,220	–	–	﹤0.01%	1490
2019 Q4	$466K	Hold	17,220	–	–	﹤0.01%	1508
2019 Q3	$468K	Hold	17,220	–	–	0.01%	1455
2019 Q2	$515K	Sell	17,220 -34,440	-67%	-$1.02M	0.01%	1462
2019 Q1	$1.51M	Buy	51,660 +34,440	+200%	+$983K	﹤0.01%	1425
2018 Q4	$489K	Hold	17,220	–	–	0.01%	1382
2018 Q3	$606K	Hold	17,220	–	–	0.01%	1412
2018 Q2	$480K	Hold	17,220	–	–	0.01%	1424
2018 Q1	$345K	Hold	17,220	–	–	﹤0.01%	1600
2017 Q4	$330K	Buy	+17,220	New	+$345K	﹤0.01%	1651

Other funds holding AORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JIC

Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

MetLife Investment Management's AORT Position: Q2 2026 in Review

MetLife Investment Management increased its Artivion (AORT) stake by 14% in Q2 2026, buying an estimated $90.5K and bringing the position to 26,749 shares worth $601K. The position accounts for ﹤0.01% of the portfolio, ranked #1808.

MetLife Investment Management first reported a position in AORT in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.51M in Q1 2019. 206 funds tracked by Wall St. Rank hold AORT as of Q2 2026.

MetLife Investment Management held 26,749 shares of Artivion worth $601K as of Q2 2026.
MetLife Investment Management bought 3,235 Artivion shares in Q2 2026, an estimated $90.5K.
Artivion made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1808 holding.
MetLife Investment Management first reported a position in Artivion in Q4 2017 and has held it in 35 quarters since.
MetLife Investment Management's Artivion position peaked at $1.51M in Q1 2019.
206 funds tracked by Wall St. Rank held Artivion as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.